Acute liver injury after transcatheter arterial chemoembolization in patients with hepatitis B virus-related intermediate or advanced hepatocellular carcinoma stages
World Journal of Gastroenterology · 28.06.2026 · 32 (24)
DOI: 10.3748/wjg.118709 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 28.06.2026. Verfasst von Xin-Hui Jie und 3 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Acute liver injury (ALI) is a prevalent complication following transcatheter arterial chemoembolization (TACE), a procedure frequently used in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). This complication may break the treatment schedule and have a negative influence on the clinical outcomes. AIM To determine the risk factors for post-TACE ALI and establish nomogram for personalized prediction in patients with HBV-related intermediate-to-advanced HCC. METHODS This retrospective study encompassed 172 patients with HBV-related intermediate to advanced HCC who underwent TACE from January 2019 to December 2024. Patients were categorized into ALI and non-ALI groups. Clinical data were collected within one week before and after TACE. A predictive nomogram was constructed based on independent risk factors identified by multivariate logistic regression. The discriminative ability, calibration, and clinical net benefit of this model were validated using receiver operating characteristic curves (area under the curve), calibration curves, and decision curve analysis. RESULTS The retrospective study was based on clinical and laboratory data from 172 patients with a clinical diagnosis of HBV-related HCC and who received TACE treatment. Of these, 62 patients (36.0%) developed ALI. Multivariate analysis revealed Child-Pugh stage (A vs B/C), number of TACE treatments, and HBV DNA levels (≥ 20 IU/mL) as independent predictors of ALI (P < 0.05). A nomogram incorporating these variables was developed to facilitate individualized risk assessment. CONCLUSION Child-Pugh stage, number of TACE treatments, and HBV DNA load are significant predictors of ALI following TACE in patients with HBV-related intermediate or advanced HCC. By integrating these variables, the proposed nomogram provides a practical tool for individualized risk assessment and may assist in perioperative management and treatment planning. External validation through multicenter prospective studies is warranted.
Zitieren
APA
Jie, X., Xi, D., Zhang, S., & Yan, X. (2026). Acute liver injury after transcatheter arterial chemoembolization in patients with hepatitis B virus-related intermediate or advanced hepatocellular carcinoma stages. World Journal of Gastroenterology, 32(24). https://doi.org/10.3748/wjg.118709
Vancouver
Jie X, Xi D, Zhang S, Yan X. Acute liver injury after transcatheter arterial chemoembolization in patients with hepatitis B virus-related intermediate or advanced hepatocellular carcinoma stages. World Journal of Gastroenterology. 2026;32(24). doi:10.3748/wjg.118709
BibTeX
@article{Jie2026,
author = {Jie, Xin-Hui and Xi, De-Yang and Zhang, Shuang-Shuang and Yan, Xue-Bing},
title = {Acute liver injury after transcatheter arterial chemoembolization in patients with hepatitis B virus-related intermediate or advanced hepatocellular carcinoma stages},
journal = {World Journal of Gastroenterology},
year = {2026},
volume = {32},
number = {24},
doi = {10.3748/wjg.118709}
}
EUVIMED